<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02531711</url>
  </required_header>
  <id_info>
    <org_study_id>14-2321</org_study_id>
    <nct_id>NCT02531711</nct_id>
  </id_info>
  <brief_title>Chronic Lumbosacral Radiculopathy: Impact of an Analgesic Dietary Intervention on Pain &amp; Function</brief_title>
  <acronym>LRPD</acronym>
  <official_title>Chronic Lumbosacral Radiculopathy: Impact of an Analgesic Dietary Intervention on Pain &amp; Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>North American Spine Society (NASS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayday Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this proposed research is to assess the preliminary efficacy of dietary&#xD;
      interventions that change dietary fats in improving clinical outcomes related to lumbar&#xD;
      radicular pain. After a two-week baseline, consented participants are randomized to one of&#xD;
      two diets. Key foods consistent with the diet are provided for 12 weeks along with extensive&#xD;
      dietary counseling and support from the study-provided materials. Participants are encouraged&#xD;
      to follow the assigned diet for another 6 weeks without provision of food.&#xD;
&#xD;
      Participants complete questionnaires at baseline, randomization, and after 6 weeks, 12 weeks,&#xD;
      and 18 weeks on the diet. They provide blood samples at randomization (2 weeks) and after 12&#xD;
      and 18 weeks on the diet.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lumbar radiculopathy is a fairly common pain syndrome which may result in chronic, severe&#xD;
      disability. There are few successful treatment options for patients with persistent&#xD;
      lumbosacral radicular pain (LRP) that does not respond to conventional approaches. A&#xD;
      fundamental biologic mechanism of chronic LRP, as well as other chronic pain syndromes, may&#xD;
      involve failure of inflammation-resolution, an active process driven by lipid mediators&#xD;
      derived from fatty acids (resolvins, protectins, maresins). The investigators' preliminary&#xD;
      studies indicate that dietary modifications, specifically increasing some dietary fatty&#xD;
      acids, while reducing others, result in large, statistically significant and clinically&#xD;
      relevant improvement in headache frequency, intensity, and other clinical outcomes in&#xD;
      community dwelling persons with chronic headaches.&#xD;
&#xD;
      The proposed trial represents a promising approach to treatment of a disabling condition,&#xD;
      lumbar radiculopathy. The previous headache trial by the investigators' interdisciplinary&#xD;
      UNC/NIH team demonstrated that specific dietary manipulations can produce marked biochemical&#xD;
      changes and have a major positive clinical impact. This project promises to enhance the&#xD;
      generalizability of the investigators' approach by expanding from chronic headaches to&#xD;
      another common chronic pain condition, and also by using a more cost-effective intervention.&#xD;
      Because dietary modification is a relatively safe and low-cost health-improvement strategy,&#xD;
      the long-term outcome of this research may be to empower individuals to take a more active&#xD;
      role in their own health through dietary changes that reduce dependence on medical&#xD;
      treatments, while providing significant clinical benefits.&#xD;
&#xD;
      Baseline Phase. Medical records will be obtained for the participant's history and physical&#xD;
      examination (performed by referring physician at the Spine Center). The baseline visit will&#xD;
      consist of review of inclusion/exclusion criteria and the components of the study prior to&#xD;
      consenting. Those who wish to sign the consents will complete baseline assessment instruments&#xD;
      that measure lumbosacral radiculopathy characteristics and their impact on quality-of-life.&#xD;
      Through electronic diaries, participants will provide daily data on pain intensity, duration,&#xD;
      function, sleep quality, and medication use over a 2-week baseline phase. Participants who&#xD;
      are compliant with all aspects of data collection, and who experience daily radicular pain,&#xD;
      will be eligible for study intervention participation.&#xD;
&#xD;
      Randomization. At the end of the 2-week baseline phase, participants who qualify will be&#xD;
      randomized (computer-generated variable permuted block) to: 1) the High n-3, Low n-6 Diet&#xD;
      (Analgesic Diet); or 2) the Control Diet. Blood will be collected for baseline biomarker&#xD;
      assessment prior to beginning study diets.&#xD;
&#xD;
      Post Randomization. After randomization, participants will attend an initial, in-depth&#xD;
      dietary counseling session administered by the registered dietitian. Participants will be&#xD;
      asked to provide a dietary history and will receive detailed instruction in the specific&#xD;
      dietary intervention per group assignment. Participants in each group will attend a total of&#xD;
      3 in-person follow-up sessions with the dietitian, for review of their dietary experiences,&#xD;
      to receive encouragement, to clarify issues, and to have questions answered. At each visit,&#xD;
      the dietitian will obtain a dietary history and assessment, provide tailored counseling, and&#xD;
      record data for evaluation of participant variability in order to guide future sessions.&#xD;
      Participants will have a visit with the dietitian at randomization, two weeks later, 4 weeks&#xD;
      after that, and 6 weeks after that (at the end of the intervention). In addition, individuals&#xD;
      will participate in brief (15-20 minute) check-in telephone calls with the dietitian every&#xD;
      2-3 weeks. Participants will have contact with the research assistant twice weekly to&#xD;
      encourage diary completion and to invite adverse event reporting.&#xD;
&#xD;
      During the 12-week intervention phase (weeks 2-14), participants will be provided with&#xD;
      essential foods to enable them to follow diet recommendations, including study oils, salad&#xD;
      dressings, and unprepared protein sources (meat, beans, fish). For the remainder of their&#xD;
      meals, participants will choose food products consistent with their assigned diet. At the&#xD;
      conclusion of the post-intervention phase (Week 20, Diet week 18), participants will complete&#xD;
      on-line questionnaires and provide blood samples. The purpose of this post-intervention phase&#xD;
      is: 1) to obtain pilot data on the ability of participants to continue to achieve nutrient&#xD;
      intake targets without counseling and food provision; and 2) to obtain pilot data on the&#xD;
      post-intervention trajectory of biochemical and clinical outcomes.&#xD;
&#xD;
      Throughout the 12-week active intervention and the 6-week post-intervention phases,&#xD;
      participants will have access to detailed intervention materials. Diet education materials&#xD;
      include the diet guidelines, allowed food list, how to read food labels, grocery shopping&#xD;
      guides for 9 local grocery stores, dining out guide, 7-day meal plan and 75 recipes with the&#xD;
      ability for the dietitian to add more.&#xD;
&#xD;
      Food Supply. Participants will visit the dietitian 3 times during the 12-week active&#xD;
      intervention to obtain specific food items with targeted nutrient compositions. Food items&#xD;
      will include: cooking oils, salad dressings, mayonnaise, portable dressing packets,&#xD;
      unprepared frozen food items, and key ingredients for home preparation of meals and snacks.&#xD;
      All foods have been specifically selected to ensure that participants meet specific nutrient&#xD;
      intake targets. Prior nutrient analyses of more than 80 relevant food items was performed as&#xD;
      part of the investigators' previous dietary intervention study in participants with chronic&#xD;
      daily headache, by the National Institutes of Health-National Institute on Alcohol Abuse and&#xD;
      Alcoholism Section of Nutritional Neurosciences (SNN). The SNN has agreed to provide further&#xD;
      nutrient analysis as needed for the proposed study.&#xD;
&#xD;
      Assessments. Throughout the 2-week baseline, the 12-week active intervention, and 6-week&#xD;
      post-intervention phases, all participants will record pain intensity, pain interference,&#xD;
      medication use, activity, and stress using a daily pain diary accessed by mobile device.&#xD;
&#xD;
      Blood samples will be collected during three visits at the end of the baseline phase (Week 2,&#xD;
      Diet week 0) and then at study Weeks 14 and 20 (at the end of the active intervention and at&#xD;
      the end of the post-intervention period) for nutritional and metabolic biomarker measurement.&#xD;
      At each sample collection visit (and after 6 weeks on the diet), participants will also&#xD;
      complete the Oswestry Disability Index (ODI) and NIH PROMIS-29 battery (physical function,&#xD;
      anxiety, depression, fatigue, sleep disturbance, satisfaction with social role, pain&#xD;
      interference, pain intensity). Every 6 weeks, participants will also be asked about their use&#xD;
      of other modalities for pain control, including physical therapy, spinal manipulation,&#xD;
      epidural corticosteroid injections, acupuncture, and yoga.&#xD;
&#xD;
      Interventions. All participants will receive: 1) tailored dietitian-administered counseling&#xD;
      consistent with the group assignment; 2) access to intervention-specific informational&#xD;
      materials and daily outcome assessments; and 3) critical food items with precisely quantified&#xD;
      fatty acid composition, selected to meet nutrient intake targets specific for each of the&#xD;
      assignment groups.&#xD;
&#xD;
      Random Allocation. At the first intervention visit, At Week 2, the research dietitian will&#xD;
      enter the participant's assigned ID into an online computer program that will determine&#xD;
      assignment to one of the two diets. Using a random number sequence to generate a permuted&#xD;
      block of 2-4, the program ensures equal numbers of participants in each arm. The program&#xD;
      documents treatment assignment in an un-editable form including a date stamp.&#xD;
&#xD;
      Masking. The research staff, masked to treatment assignment, will schedule all study-related&#xD;
      visits in the Clinical and Translational Research Center (CTRC) or other appropriate site in&#xD;
      the University of North Carolina (UNC) Healthcare system or medical school. Only the&#xD;
      dietitian will, of necessity, be unmasked. All investigators and laboratory personnel will be&#xD;
      masked to dietary assignment. Masking will be maintained in the random allocation procedure.&#xD;
      The research dietitian will not indicate to participants which diets are considered to be&#xD;
      treatment diets vs. the control diet.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2015</start_date>
  <completion_date type="Actual">December 30, 2019</completion_date>
  <primary_completion_date type="Actual">December 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oswestry Disability Index--Primary clinical outcome</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measure of pain-specific quality of life</description>
  </primary_outcome>
  <primary_outcome>
    <measure>17-Hydroxy Docosahexaenoic acid (DHA)--Primary biochemical outcome</measure>
    <time_frame>12 weeks</time_frame>
    <description>Metabolite related to dietary fatty acid intakes implicated in pain reductions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>12 weeks</time_frame>
    <description>Average weekly pain intensity, measured in daily diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>12 weeks</time_frame>
    <description>Average weekly steps per day, measured by pedometer (Fitbit)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep efficiency</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measured by percent of time asleep out of total time in bed (Fitbit)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep quantity</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measured by average weekly hours of sleep (Fitbit)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported health</measure>
    <time_frame>12 weeks</time_frame>
    <description>PROMIS-29: includes physical function, social functioning, psychological distress, sleep quality, and fatigue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Red blood cell fatty acids</measure>
    <time_frame>Measured at Week 2 and after 6 and 12 weeks on the diet</time_frame>
    <description>Measures adherence to dietary recommendations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Borkovec and Nau scale</measure>
    <time_frame>Measured at Week 2</time_frame>
    <description>Measures credibility and expectation of benefit</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Diet A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dietary intervention: Dietary fats are adjusted. Key study foods and oils are provided for 12 weeks. Participants learn which foods to eat and which to avoid.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diet B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dietary intervention: This diet also adjusts dietary fats, and provides key study foods and oils for 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet A</intervention_name>
    <description>Experimental analgesic dietary intervention</description>
    <arm_group_label>Diet A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet B</intervention_name>
    <description>Healthy comparator diet</description>
    <arm_group_label>Diet B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        MRI-verified lumbosacral radiculopathy associated with herniated disc, spinal stenosis, or&#xD;
        post-surgical fibrosis&#xD;
&#xD;
          -  Pain reaching to the knee for at least 12 weeks&#xD;
&#xD;
          -  Willing to complete daily diary for 20 weeks, as evidenced by completion of â‰¥12 of the&#xD;
             first 14 days&#xD;
&#xD;
          -  Possessing a mobile device (smart phone, tablet, laptop) capable of accessing the&#xD;
             application and website&#xD;
&#xD;
          -  Able to attend dietitian counseling sessions in Chapel Hill, NC&#xD;
&#xD;
          -  Under care of a physician for LR&#xD;
&#xD;
          -  Able to read and communicate in English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Psychosis or severe depression, anxiety, substance abuse disorder&#xD;
&#xD;
          -  History of specific food allergies that would prevent adherence to study diet&#xD;
&#xD;
          -  Aversion to eating fish&#xD;
&#xD;
          -  Currently taking fish oil or other supplements that contain fatty acids under&#xD;
             investigation&#xD;
&#xD;
          -  Pregnancy or anticipated pregnancy&#xD;
&#xD;
          -  Active treatment for a major medical illness, such as malignancy, autoimmune, immune&#xD;
             deficiency disorder&#xD;
&#xD;
          -  History of vasculitis, intracranial mass, clotting disorder (including&#xD;
             medication-induced, e.g., warfarin)&#xD;
&#xD;
          -  Cognitive dysfunction preventing informed consent&#xD;
&#xD;
          -  Pending personal injury litigation, including worker's compensation&#xD;
&#xD;
          -  Chronic long-term disability related to lumbosacral injury/symptoms&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevin Carneiro, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Physical Medicine and Rehabilitation, University of North Carolina at Chapel Hill</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599-7200</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>June 8, 2015</study_first_submitted>
  <study_first_submitted_qc>August 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2015</study_first_posted>
  <last_update_submitted>October 7, 2020</last_update_submitted>
  <last_update_submitted_qc>October 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lumbosacral</keyword>
  <keyword>radicular</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Radiculopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Deidentified data will be shared with investigators at NIH.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

